Blood

Keyphrases

Publications

volume 142, number 20, 2023

Stephanie Z Xie
Sphingolipids and HSC fitness: enigma no more. Blood 142 (20) (2023)
Lauren K Meyer, Kim E Nichols
Hyperactive TLR signaling: putting the "H" in H syndrome. Blood 142 (20) (2023)
Bernhard Strasser, Alexander Haushofer
Cabot rings in chronic myelomonocytic leukemia. Blood 142 (20) (2023)

volume 142, number 21, 2023

Shai Shimony, Marlise R Luskin
Unraveling KMT2A-rearranged ALL. Blood 142 (21) (2023)
Liliana E Lucca
Multiple myeloma treatment: one bridge closer. Blood 142 (21) (2023)
Motoko Koyama
A potential tissue-based biomarker in gut GVHD. Blood 142 (21) (2023)
Elisa Lin, Weina Chen
Acute myeloid leukemia with NUP98::HOXA9 mimicking acute promyelocytic leukemia. Blood 142 (21) (2023)
Kaosheng Lv, Wei Tong
Hidden conformational codes. Blood 142 (21) (2023)
Matthew S Davids
Functional cure reported in CLL. Blood 142 (21) (2023)

volume 142, number 22, 2023

Domenico Girelli, Giacomo Marchi
Deironing the spleen with luspatercept. Blood 142 (22) (2023)
Maria Therese Ahlen, James Bruce Bussel
Desialylation unmasks HPA-9B alloantibodies. Blood 142 (22) (2023)
Paul S de Vries
Genetics of predicted platelet reactivity. Blood 142 (22) (2023)
Erica M Sparkenbaugh, Jane A Little
Cold comfort in sickle cell disease. Blood 142 (22) (2023)
Leo Rasche, Niels Weinhold
When a solitary plasmacytoma is just the beginning…. Blood 142 (22) (2023)
Hilka Rauert-Wunderlich
EGR1 changes course in B-cell lymphoma. Blood 142 (22) (2023)
Jennifer Cai, Jennifer M Lee
Cold agglutinin syndrome with unexpected bone marrow CD5+ diffuse large B-cell lymphoma. Blood 142 (22) (2023)

volume 142, number 3, 2023

Luca Malcovati
VEXAS: walking on the edge of malignancy. Blood 142 (3) (2023)
Maria Monica J Gramatges
Poverty and health equity in childhood leukemia. Blood 142 (3) (2023)
Alexandra Veloso, Jan Cools
Targeting STAT5B in T-cell acute lymphoblastic leukemia. Blood 142 (3) (2023)
David G J Cucchi, Sonja Zweegman
Equality: trial and error? Blood 142 (3) (2023)
Kathleen P Pratt
Factor VIII forges its own path. Blood 142 (3) (2023)

volume 142, number 4, 2023

Dagmar Gotthardt
Targeting iron import to treat ANKL. Blood 142 (4) (2023)
Aaron D Schimmer
ZDHHC21: a mitochondrial vulnerability in AML. Blood 142 (4) (2023)
Katherine M Morgan, Payal Sojitra
Auer rod-like inclusions in chronic lymphocytic leukemia. Blood 142 (4) (2023)
Camila Masias
The impact of TTP in the brain. Blood 142 (4) (2023)

volume 142, number 5, 2023

Emily Symes, Girish Venkataraman
Peripheral T-cell lymphoma with TFH phenotype and associated indolent T-lymphoblastic proliferation. Blood 142 (5) (2023)
Antonio Pierini
No tolerance with immune suppression! Blood 142 (5) (2023)
Stephen P Mulligan
Karyotype and outcome in CLL. Blood 142 (5) (2023)
Katharina S Götze
Flipping the switch in the stem cell niche. Blood 142 (5) (2023)
Ankit A Desai
Ventricular arrhythmias in sickle cell anemia. Blood 142 (5) (2023)
Nader El-Mallawany Kim, Kala Y Kamdar
Evolving beyond morphology in pediatric PTLD. Blood 142 (5) (2023)

volume 142, number 6, 2023

Yanna Ding, Elaine S Jaffe
Follicular lymphoma involving the synovium in rheumatoid arthritis. Blood 142 (6) (2023)
Maiko Sezaki, Gang Huang
Food for thought (and CML survival). Blood 142 (6) (2023)
John D Crispino
Introduction to a review series on hematopoietic stem cells. Blood 142 (6) (2023)
James D Phelan, Elaine S Jaffe
An AID to follicular lymphoma transformation. Blood 142 (6) (2023)
Daniel Molin
NLPHL: a hummingbird in an owl's nest. Blood 142 (6) (2023)
János G Filep
Resolvin D4 disengages emergency granulopoiesis. Blood 142 (6) (2023)

volume 142, number 7, 2023

Annapurna Saksena, Ankit Rajgariah
A novel case of peripheral T-cell lymphoma, not otherwise specified, with rhabdoid morphology and INI1 loss. Blood 142 (7) (2023)
Enrica Marchi
PTCL and ICIs: a matter of time and subtype. Blood 142 (7) (2023)
Lucy A Godley
Germ line risk variants: beyond cancer. Blood 142 (7) (2023)
Helen S Goodridge
Progenitor diversity defines monocyte roles. Blood 142 (7) (2023)
Takahiro Maeda
CELMoD for ALL: an exciting prospect. Blood 142 (7) (2023)

volume 142, number 8, 2023

John W Weisel
Improving clots in trauma. Blood 142 (8) (2023)
Carsten Utoft Niemann
BTK inhibitors: safety + efficacy = outcome. Blood 142 (8) (2023)
Karen R Rabin
Insights into the genomics of iAMP21-ALL. Blood 142 (8) (2023)
Francesca Bonifazi
GVHD: better safe than sorry. Blood 142 (8) (2023)

volume 142, number 9, 2023

Marc Bosch-Schips, Mayda Navarrete
Diagnostic peripheral blood smear for Chédiak-Higashi syndrome in a 43-month-old boy, confirmed by sequencing. Blood 142 (9) (2023)
Gregory Sampang Calip, Trevor J Royce
External validity of lymphoma clinical trials. Blood 142 (9) (2023)
Pamela B Allen
DMF in CTCL: where do we go from here? Blood 142 (9) (2023)
Feyisayo Eweje, Daniel E Bauer
A viable alternative for editor delivery. Blood 142 (9) (2023)